Drugs · acquisition-cost intelligence
Prednisolone
· ingredient prednisoloneCorticosteroids· PREDNISOLONE 5 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$8.48
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other prednisolone products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Prednisolone Sodium Phosphate Oral Solution | $0.10570 | −$8.37 |
| prednisolone sodium phosphate | $0.54135 | −$7.94 |
| Prednisolone | $0.57671 | −$7.90 |
| Prednisolone Sodium Phosphate | $2.43 | −$6.05 |
| PRED FORTE | $4.65 | −$3.83 |
| PREDNISOLONE SODIUM PHOSPHATE | $4.89 | −$3.60 |
| PRED MILD | $30.68 | +$22.20 |
Medicare Part D coverage · CY2026
On 23 plan formularies · typical tier 2
Prior auth 26% · Step therapy 0% · Quantity limit 0% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.